Application Value of Iodine-131 Combined with Levothyroxine Sodium in Patients with Differentiated Thyroid Cancer after Surgery

甲状腺癌 左旋甲状腺素 医学 碘 甲状腺 癌症 钠 外科 泌尿科 内科学 内分泌学 化学 有机化学
作者
Jinmiao Wang,Jie Hao,Ying Gao,Shoujun Wang,Duowei Wang,Weijie Tao,Ran Duan,Zhendong Zhang,Ming Gao
出处
期刊:Oncology [Karger Publishers]
卷期号:103 (5): 1-9 被引量:1
标识
DOI:10.1159/000541546
摘要

INTRODUCTION: This study aimed to evaluate the clinical value of iodine-131 combined with levothyroxine sodium in the treatment of patients with differentiated thyroid cancer (DTC) after surgery. METHODS: Prospective randomized controlled studies were conducted. A total of 374 DTC patients who underwent total or near-total thyroidectomy in the Department of Thyroid Surgery, Tianjin Union Medical Center and Tianjin Medical University General Hospital, from January 2019 to February 2022 were selected and divided into control group (187 cases) and observation group (187 cases) according to random number table method. The control group was treated with levothyroxine sodium after surgery, and the observation group was treated with iodine-131 on the basis of the control group. Gender, age, course of disease, tumor diameter, pathological type, TNM classification, treatment effect, thyroglobulin (Tg) levels before and after treatment, SF-36 health status questionnaires (SF-36), occurrence of adverse reactions after treatment, and recurrence rate of 1-year follow-up were compared and analyzed between the two groups. RESULTS: There was no significant difference in baseline data between the two groups. After treatment, the effective rate of the observation group increased by 11.23% compared to the control group, with a statistically significant difference (91.98% vs. 80.75%, p < 0.05). There was no significant difference in Tg level and scores of SF-36 evaluation including physical functioning, physical problems, vitality, pain, mental health, emotional problems, social functioning, and general health perception between the two groups before surgery (p > 0.05), Tg levels and scores of SF-36 evaluation in all dimensions were significantly improved in both groups after treatment (p < 0.05), and the levels of Tg and scores of SF-36 in all dimensions in observation group were significantly better than those in control group after treatment (p < 0.001). There was no significant difference in the incidence of adverse reactions between the two groups (p > 0.05). The recurrence rate in the observation group was 5.89% lower than that in the control group 1 year after treatment, with a statistically significant difference (2.67% vs. 8.56%, p < 0.05). CONCLUSIONS: The combination of iodine-131 and levothyroxine sodium in the postoperative treatment of DTC can improve the therapeutic effect and reduce the postoperative recurrence rate without increasing adverse reactions, which is worthy of clinical reference and promotion.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
siraotianya完成签到,获得积分10
刚刚
w0304hf发布了新的文献求助10
1秒前
1秒前
abcde发布了新的文献求助10
1秒前
2秒前
ding的应助被健壮的化蛹采纳,获得30
2秒前
yy关注了科研通微信公众号
2秒前
千云皆墨完成签到,获得积分10
2秒前
儒雅从安发布了新的文献求助10
2秒前
3秒前
飘飘完成签到,获得积分10
3秒前
4秒前
Agnes完成签到,获得积分10
4秒前
小鱼歪优完成签到 ,获得积分10
4秒前
ZXH完成签到,获得积分10
4秒前
4秒前
4秒前
汉堡包的应助被零慧采纳,获得10
5秒前
豆子完成签到,获得积分10
5秒前
5秒前
蒙哥卡恩完成签到 ,获得积分10
6秒前
打打的应助被苦瓜采纳,获得10
6秒前
现代秋天发布了新的文献求助30
7秒前
7秒前
找到了没完成签到,获得积分10
8秒前
超牛的开心果关注了科研通微信公众号
8秒前
RXAFSH发布了新的文献求助30
8秒前
今天看文献了吗完成签到 ,获得积分10
8秒前
干鞅发布了新的文献求助10
8秒前
豆子发布了新的文献求助10
9秒前
9秒前
勤恳依秋发布了新的文献求助10
9秒前
9秒前
wewe发布了新的文献求助30
10秒前
顺心绮兰完成签到,获得积分10
10秒前
天天快乐的应助被water采纳,获得10
11秒前
13秒前
14秒前
SciGPT的应助被呼呼夫人采纳,获得10
14秒前
Lucas的应助被1122采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194239
求助须知:如何正确求助?哪些是违规求助? 9580103
关于积分的说明 21869458
捐赠科研通 7793840
什么是DOI,文献DOI怎么找? 3437562
关于科研通互助平台的介绍 2560983
邀请新用户注册赠送积分活动 2484332